Anterogen.Co.,Ltd. (KOSDAQ:065660)
12,980
-570 (-4.21%)
Nov 20, 2026, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 129.88 billion as of November 20, 2026. It is the 24,791st most valuable company in the world and the 1,008th biggest in South Korea. Its market cap has decreased by 44.05% in one year.
Market Cap
129.88B
Enterprise Value
86.03B
Revenue
9.29B
Global Rank
Country Rank
#1,008 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 129.88B, a decrease of -55.49%. That is a compound annual growth rate of -7.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 129.88B | -72.29% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 200.55B |
| Genomictree | 198.81B |
| GC Genome | 182.58B |
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| NeoImmuneTech | 139.40B |
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |